Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of Olanzapine for the Control of Chemotherapy-induced Vomiting in Children Receiving Highly Emetogenic Chemotherapy

NCT03118986 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT03118986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03118986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of Olanzapine for the Control of Chemotherapy-induced Vomiting in Children Receiving Highly Emetogenic Chemotherapy
Lead sponsor
The Hospital for Sick Children
Phase
Phase 2
Overall status
Completed
Start date
August 10, 2017
Completion date
June 12, 2026
Enrollment
161 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic system--cancer, nausea, oncology, vomiting in infants and/or children